Atlas Trials

A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer

Clinical trial NCT00585533 · COMPLETED

Trial details

NCT number
NCT00585533
Sponsor
University of Utah
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2004-06-01
Primary completion
2012-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.